← Eichor
Study identifier: NCT06118554 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

3D Printing to Improve Nasal Irrigation Outcome

Condition: Chronic Rhinosinusitis With Nasal Polyps · Chronic Rhinosinusitis Without Nasal Polyps  ·  Sponsor: Ohio State University

PhaseNA
Planned participants200
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

Three-dimensional (3D) printing has been an emerging technology with uses in a wide array of fields. This research aims to use 3D printing as a tool to provide personalized education to maximize treatment efficacy based on the patient's individual anatomy. With increased irrigation to the sinuses, we hypothesize there will be improved patient satisfaction and higher quality of life. The outcomes of this research could lead to a new option for patients who live with chronic rhinosinusitis are not candidates for surgery or are interested in less invasive options. The 3D printed nasal replica is not something that would be implanted, rather it is a hand-held device used specifically for participants to better understand their nasal anatomy.

This description comes directly from the study's public registry record.

Talk to the study team

Kai Zhao, PhD  ·  2673032322  ·  zhao.1949@osu.edu

Zachary T. Root, BS  ·  6145609257  ·  zachary.root@osumc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

The Ohio State University Eye and Ear InstitueColumbus, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06118554